Y-Intercept (HK)’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Y-Intercept (HK)’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-39,772	Closed	-$131K	–	1735
2023 Q2	$131K	Buy	+39,772	New	+$120K	0.01%	1016
2023 Q1	–	Sell	-5,586	Closed	-$65.5K	–	1627
2022 Q4	$65.5K	Buy	+5,586	New	+$98.5K	0.01%	908
2022 Q3	–	Sell	-1,821	Closed	-$44K	–	1345
2022 Q2	$44K	Buy	+1,821	New	+$62K	0.01%	761

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Y-Intercept (HK)'s VBIV Position: Q3 2023 in Review

Y-Intercept (HK) sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2023, closing a stake of 39,772 shares — an estimated $131K sold.

Y-Intercept (HK) first reported a position in VBIV in Q2 2022 and held it in 3 quarters. The position peaked at $131K in Q2 2023. 37 funds tracked by Wall St. Rank hold VBIV as of Q3 2023.

Y-Intercept (HK) reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2023 after selling out during the quarter.
Y-Intercept (HK) sold 39,772 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2023, an estimated $131K.
Y-Intercept (HK) first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2022 and held it in 3 quarters.
Y-Intercept (HK)'s VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $131K in Q2 2023.
37 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.